Recombinant Human MBL Protein, CF

Images

 
When Mannan is coated at 0.1 µg/mL (100 µL/well), Recombinant Human MBL (Catalog # 9086-MB) binds with a typical ED50 of 25-150 ng/mL.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Bioactivity
Format
Carrier-Free

Order Details

Recombinant Human MBL Protein, CF Summary

Details of Functionality
Measured by its binding ability in a functional ELISA. When Mannan is immobilized at 0.1 µg/mL (100 µL/well), the concentration of Recombinant Human MBL that produces 50% of the optimal binding response is approximately 25-150 ng/mL.
Source
Human embryonic kidney cell, HEK293-derived human MBL protein
Glu21-Ile248
Accession #
N-terminal Sequence
Glu21
Protein/Peptide Type
Recombinant Proteins
Gene
MBL2
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Bioactivity
Theoretical MW
24 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
31-36 kDa, reducing conditions
Publications
Read Publications using
9086-MB in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS and Trehalose.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 500 μg/mL in PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human MBL Protein, CF

  • COLEC1
  • COLEC1collectin-1
  • Collectin-1
  • HSMBPC
  • Mannan-binding protein
  • mannose-binding lectin (protein C) 2, soluble (opsonic defect)
  • mannose-binding lectin (protein C) 2, soluble
  • Mannose-binding lectin
  • mannose-binding protein C
  • MBL
  • MBL2
  • MBL2D
  • MBLmannan-binding lectin
  • MBP
  • MBP1
  • MBP1mannose-binding lectin 2, soluble (opsonic defect)
  • MBP-C
  • MGC116832
  • MGC116833

Background

Human mannose/mannan-binding lectin (MBL) is a 25-30 kDa secreted glycoprotein in the collectin family of pattern-recognition molecules (1, 2). Mature human MBL contains a cysteine-rich region, a collagen-like segment, and a C-type lectin domain that binds to neutral bacterial carbohydrates (3). Human MBL shares 61% amino acid sequence identity with mouse and rat MBL and carries variable post-translation modifications including O-glycosylation and proline and lysine hydroxylation (4). Its collagen-like region mediates MBL association into disulfide-stabilized trimers which further associate into complexes containing three or four copies of the basic trimer (4, 5). MBL is secreted by hepatocytes and opsonizes bacteria through interactions with microbial carbohydrates (5). Tetrameric complexes of MBL show greater carbohydrate binding capacity compared to the trimers (5). MBL multimers can associate with the serine proteases MASP-1, -2, and -3 and promote their cleavage of Complement Component C3 (5-8). Proteolytic cleavage of C3 triggers activation of the complement system and formation of the membrane attack complex, leading to destruction of opsonized bacteria (2). In addition, MBL binds to the scavenger receptor CD91 which mediates the clearance of apoptotic material (9).
  1. Scorza, M. et al. (2015) Clin. Chim. Acta 451:78.
  2. Matsushita, M. et al. (2013) Arch. Immunol. Ther. Exp. (Warsz.) 61:273.
  3. Ezekowitz, R.A.B. et al. (1988) J. Exp. Med. 167:1034.
  4. Jensen, P.H. et al. (2005) J. Biol. Chem. 280:11043.
  5. Teillet, F. et al. (2005) J. Immunol. 174:2870.
  6. Moller-Kristensen, M. et al. (2007) Int. Immunol. 19:141.
  7. Thiel, S. et al. (2000) J. Immunol. 165:878.
  8. Vorup-Jensen, T. et al. (2000) J. Immunol. 165:2093.
  9. Duus, K. et al. (2010) FEBS J. 277:4956.

Customers Who Viewed This Item Also Viewed...

NBP1-58986
Species: Hu
Applications: IHC, IHC-P, WB
NBP1-87781
Species: Hu, Mu
Applications: IHC, IHC-P, WB
NB300-141
Species: Bv, Ch, Eq, Gp, Hu, Mu, Po, Rb, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
538-MG
Species: Rt
Applications: BA
H00004340-B01P
Species: Hu, Rt
Applications: WB
NBP2-93574
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
MAB6734
Species: Hu
Applications: IHC
AF5724
Species: Hu, Mu, Rt
Applications: ICC, WB
NB200-540
Species: Ec, Mu
Applications: CyTOF-ready, Flow-IC, Flow, IA, ICC/IF, IHC, IHC-Fr, IHC-P, IP
6507-IL/CF
Species: Hu
Applications: BA
NBP2-34234
Species: Hu
Applications: ELISA, ICC/IF, IHC, IHC-P
202-IL
Species: Hu
Applications: BA
7954-GM/CF
Species: Hu
Applications: BA
NBP1-88027
Species: Eq, Hu, Mu, Rt
Applications: IHC, IHC-P, Simple Western, WB
NBP2-83997
Species: Hu
Applications: IHC, IHC-P, WB
NBP2-46005
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, IP, PLA, WB
AF1724
Species: Hu
Applications: IP, WB
NBP2-42388
Species: Hu
Applications: ICC/IF, IHC, IHC-P, KD, WB

Publications for MBL (9086-MB)(8)

We have publications tested in 6 confirmed species: Human, Fasciola hepatica, Fungus - Aspergillus fumigatus, Hamster, Parasite - Borrelia burgdorferi, Yeast.

We have publications tested in 3 applications: Binding Assay, Bioassay, ELISA Capture.


Filter By Application
Binding Assay
(1)
Bioassay
(6)
ELISA Capture
(1)
All Applications
Filter By Species
Human
(2)
Fasciola hepatica
(1)
Fungus - Aspergillus fumigatus
(1)
Hamster
(1)
Parasite - Borrelia burgdorferi
(1)
Yeast
(1)
All Species
Showing Publications 1 - 8 of 8.
Publications using 9086-MB Applications Species
Dellière, S;Chauvin, C;Wong, SSW;Gressler, M;Possetti, V;Parente, R;Fontaine, T;Krüger, T;Kniemeyer, O;Bayry, J;Carvalho, A;Brakhage, AA;Inforzato, A;Latgé, JP;Aimanianda, V; Interplay between host humoral pattern recognition molecules controls undue immune responses against Aspergillus fumigatus Nature communications 2024-08-14 [PMID: 39138196] (ELISA Capture, Fungus - Aspergillus fumigatus) ELISA Capture Fungus - Aspergillus fumigatus
C De Marco V, HL Jewhurst, J Dobó, P Gál, JP Dalton, K Cwiklinski Fasciola hepatica is refractory to complement killing by preventing attachment of mannose binding lectin (MBL) and inhibiting MBL-associated serine proteases (MASPs) with serpins PloS Pathogens, 2022-01-10;18(1):e1010226. 2022-01-10 [PMID: 35007288] (Bioassay, Fasciola hepatica) Bioassay Fasciola hepatica
J Terävä, L Tiainen, U Lamminmäki, PL Kellokumpu, K Pettersson, K Gidwani Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma PLoS ONE, 2019-07-25;14(7):e0219480. 2019-07-25 [PMID: 31344060] (Bioassay, Human) Bioassay Human
J Coumou, A Wagemakers, S Narasimhan, TJ Schuijt, JI Ersoz, A Oei, OJ de Boer, JJTH Roelofs, E Fikrig, JW Hovius The role of Mannose Binding Lectin in the immune response against Borrelia burgdorferi sensu lato Sci Rep, 2019-02-05;9(1):1431. 2019-02-05 [PMID: 30723261] (Bioassay, Parasite - Borrelia burgdorferi) Bioassay Parasite - Borrelia burgdorferi
F Martini, B Eckmair, S Štefani?, C Jin, M Garg, S Yan, C Jiménez-Ca, A Hykollari, C Neupert, L Venco, D Varón Silv, IBH Wilson, K Paschinger Highly modified and immunoactive N-glycans of the canine heartworm Nat Commun, 2019-01-08;10(1):75. 2019-01-08 [PMID: 30622255] (Binding Assay) Binding Assay
NM Hammad, NE El Badawy, HA Ghramh, LM Al Kady Mannose-Binding Lectin: A Potential Therapeutic Candidate against Candida Infection Biomed Res Int, 2018-05-02;2018(0):2813737. 2018-05-02 [PMID: 29854737] (Bioassay, Yeast) Bioassay Yeast
BM Gunn, JE Jones, RS Shabman, AC Whitmore, S Sarkar, LK Blevins, TE Morrison, MT Heise Ross River virus envelope glycans contribute to disease through activation of the host complement system Virology, 2018-01-08;515(0):250-260. 2018-01-08 [PMID: 29324290] (Bioassay, Hamster) Bioassay Hamster
JC Brazil, R Sumagin, SR Stowell, G Lee, NA Louis, RD Cummings, CA Parkos Expression of Lewis-a glycans on polymorphonuclear leukocytes augments function by increasing transmigration J. Leukoc. Biol., 2017-06-09;0(0):. 2017-06-09 [PMID: 28600306] (Bioassay, Human) Bioassay Human

Reviews for MBL (9086-MB) (0)

There are no reviews for MBL (9086-MB). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for MBL (9086-MB) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional MBL Products

Blogs on MBL

There are no specific blogs for MBL, but you can read our latest blog posts.

Customers Who Bought This Also Bought

GFAP Antibody
NB300-141

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human MBL Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol MBL2
Uniprot